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CANCER OF OROPHARYNX AND
NASOPHARYNX CLlNICAL
PROGNOESTIC FACTORS ANALYSIS
M. Syguła, B. Pilecki, W. Sąsiadek, M. Goleń,
W. Przeorek, A. Wygoda, K. Składowski
Clinic ot Radiotherapy, Cancer Centre MSC
Institute, Gliwice, Poland
Analysis contains 110 cases ot oropharyngeal
and 112 cases ot nasopharyngeal cancers who
were treated beetwen 1990-1998 in MSC
Centre ot Oncology-Institute, branch Gliwice.
Main part ot histopatological tindings in
oropharyngeal area were squamous cancers,
but undifterentiated type was slightly dominated
than squamous in nasopharyngeal region.
More than halt ot cases in both localisations
were locally advanced [T3,T4] and similar,
nearly 1/3 cases were without nodal
metastases.
Comparisons beetwen mean tumor volumes
indicate on bigger cancer volume, when primary
tumor was located in oropharyngeal area, but
mean nodal volume was much higher in
nasopharyngeal cancer.
Kinetics ot distant metastases were much
higher in nasopharyngeal location ot primary
tumor especially in undifterentiated cases.
Radiotherapy was the main type ot treatment
which was realised in palliative and radical
schedule with conventional and unconventional
tractionation scheme.
Following clinical tactors were underdone
evaluation: T-stage and primary tumor volume,
N-stage with amount and volume ot nodes,
conglomerates ot nodes presence, M-stage,
type ot histological structure and treatment
tactors: tumor and nodal total doses and kind ot
tractionation.
Statistieal methods which were used
contained: single- and multivariate analysis and
logistic regression model.
Conclusion: "Hierarchy ot importance" of the
tactors which were analysed and their influences





AND RADIOTHERAPY IN CERVICAL
CANCER PATlENTS. A REPORT ON
ACUTE TOXICITY
K. Serkies, L. Krasinska, T. Sawieki, J. Jassem
Medical University ot Gdansk
Material and method: Between May 1999 and
January 2001, 41 consecutive cervical caneer
patients (pts) , median age 46 yrs (range 29-68),
were treated with concurrent eisplatin and pelvic
irradiation with curative intent (29 pts FIGO stage
IB "bulky", IIB-IVA) or postoperatively (11 pts who
had positive pelvic Iymph nodes and/or
involvement ot the surgical margin and/or large
and deeply invasive lesion). Adequate bone
marrow function and normai serum creatinine
were required. Cisplatin given as a 60-minute
intusion, was administered weekly at the dose ot
40 mg/sqm (max. 70 mg) tor six eycles.
Antiemetic therapy was routinely given. Three
patients reeeived irradiation on out-patient basis.
Results: A total ot 145 cycles were
administered. The median number ot cisplatin
eycles was 4 (range: 1-6). Overall, 65% ot pts
received at least tour cycles ot cisplatin. The
reasons tor ehemotherapy discontinuation
included low level ot creatinine clearence (2
pts), worsening of performance status (3 pts),
and myoclonia after cisplatin injection (1 pt).
Moderate emesis occurred in one patient, grade
2 leukopenia in two other cases. There were no
severe acute effects precluding the delivery ot
planned radiotherapy. At present six patients are
still on therapy.
Conclusion: Pelvie radiotherapy eombined with
weekly cisplatin is teasible in a routine practice.
This modality is also suitable tor patients treated
on out-patient basis.
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